<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
x

MuPrime™ – A Novel Mouse Model for PARP Inhibitor Evaluation

PARP inhibitors (PARPi) have seen a resurgence since their approval for BRCA mutated ovarian cancer, and are currently being investigated in other cancer types, including those with WT BRCA.